Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

1.

T-bet Runs INTERFERence.

Immunity.
Lazarevic V, Szabo S, Glimcher LH.
| Jun 20, 2017
2.

Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.

N. Engl. J. Med.
Jaiswal S, Natarajan P, Silver AJ, Gibson CJ, Bick AG, Shvartz E, McConkey M, Gupta N, Gabriel S, Ardissino D, Baber U, Mehran R, Fuster V, Danesh J, Frossard P, Saleheen D, Melander O, Sukhova GK, Neuberg D, Libby P, Kathiresan S, Ebert BL.
| Jun 21, 2017
3.

PI3K-p110α mediates the oncogenic activity induced by loss of the novel tumor suppressor PI3K-p85α.

Proc. Natl. Acad. Sci. U.S.A.
Thorpe LM, Spangle JM, Ohlson CE, Cheng H, Roberts TM, Cantley LC, Zhao JJ.
| Jun 19, 2017
4.

UCP1 deficiency causes brown fat respiratory chain depletion and sensitizes mitochondria to calcium overload-induced dysfunction.

Proc. Natl. Acad. Sci. U.S.A.
Kazak L, Chouchani ET, Stavrovskaya IG, Lu GZ, Jedrychowski MP, Egan DF, Kumari M, Kong X, Erickson BK, Szpyt J, Rosen ED, Murphy MP, Kristal BS, Gygi SP, Spiegelman BM.
| Jun 19, 2017
5.

The EGLN-HIF O2-Sensing System: Multiple Inputs and Feedbacks.

Mol. Cell.
Ivan M, Kaelin WG.
| Jun 15, 2017
6.

The NOTCH1/SNAIL1/MEF2C Pathway Regulates Growth and Self-Renewal in Embryonal Rhabdomyosarcoma.

Cell Rep.
Ignatius MS, Hayes MN, Lobbardi R, Chen EY, McCarthy KM, Sreenivas P, Motala Z, Durbin AD, Molodtsov A, Reeder S, Jin A, Sindiri S, Beleyea BC, Bhere D, Alexander MS, Shah K, Keller C, Linardic CM, Nielsen PG, Malkin D, Khan J, Langenau DM.
| Jun 13, 2017
7.

A UV-Independent Topical Small-Molecule Approach for Melanin Production in Human Skin.

Cell Rep.
Mujahid N, Liang Y, Murakami R, Choi HG, Dobry AS, Wang J, Suita Y, Weng QY, Allouche J, Kemeny LV, Hermann AL, Roider EM, Gray NS, Fisher DE.
| Jun 13, 2017
8.

The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival.

Nature.
Wang H, Nicolay BN, Chick JM, Gao X, Geng Y, Ren H, Gao H, Yang G, Williams JA, Suski JM, Keibler MA, Sicinska E, Gerdemann U, Haining WN, Roberts TM, Polyak K, Gygi SP, Dyson NJ, Sicinski P.
| Jun 15, 2017
9.

Functional proteogenomics reveals biomarkers and therapeutic targets in lymphomas.

Proc. Natl. Acad. Sci. U.S.A.
Rolland DCM, Basrur V, Jeon YK, McNeil-Schwalm C, Fermin D, Conlon KP, Zhou Y, Ng SY, Tsou CC, Brown NA, Thomas DG, Bailey NG, Omenn GS, Nesvizhskii AI, Root DE, Weinstock DM, Faryabi RB, Lim MS, Elenitoba-Johnson KSJ.
| Jun 20, 2017
10.

Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial.

Lancet.
Prince HM, Kim YH, Horwitz SM, Dummer R, Scarisbrick J, Quaglino P, Zinzani PL, Wolter P, Sanches JA, Ortiz-Romero PL, Akilov OE, Geskin L, Trotman J, Taylor K, Dalle S, Weichenthal M, Walewski J, Fisher D, Dréno B, Stadler R, Feldman T, Kuzel TM, Wang Y, Palanca-Wessels MC, Zagadailov E, Trepicchio WL, Zhang W, Lin HM, Liu Y, Huebner D, Little M, Whittaker S, Duvic M, Trotman J.
| 06 06, 2017
12.

Hypothalamic-Pituitary Axis Regulates Hydrogen Sulfide Production.

Cell Metab.
Hine C, Kim HJ, Zhu Y, Harputlugil E, Longchamp A, Matos MS, Ramadoss P, Bauerle K, Brace L, Asara JM, Ozaki CK, Cheng SY, Singha S, Ahn KH, Kimmelman A, Fisher FM, Pissios P, Withers DJ, Selman C, Wang R, Yen K, Longo VD, Cohen P, Bartke A, Kopchick JJ, Miller R, Hollenberg AN, Mitchell JR.
| Jun 06, 2017
13.

Pembrolizumab for Advanced Urothelial Carcinoma.

N. Engl. J. Med.
Bellmunt J, Bajorin DF.
| 06 08, 2017
14.

The promise of organ and tissue preservation to transform medicine.

Nat. Biotechnol.
Giwa S, Lewis JK, Alvarez L, Langer R, Roth AE, Church GM, Markmann JF, Sachs DH, Chandraker A, Wertheim JA, Rothblatt M, Boyden ES, Eidbo E, Lee WPA, Pomahac B, Brandacher G, Weinstock DM, Elliott G, Nelson D, Acker JP, Uygun K, Schmalz B, Weegman BP, Tocchio A, Fahy GM, Storey KB, Rubinsky B, Bischof J, Elliott JAW, Woodruff TK, Morris GJ, Demirci U, Brockbank KGM, Woods EJ, Ben RN, Baust JG, Gao D, Fuller B, Rabin Y, Kravitz DC, Taylor MJ, Toner M.
| Jun 07, 2017
15.

Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.

N. Engl. J. Med.
von Minckwitz G, Procter M, de Azambuja E, Zardavas D, Benyunes M, Viale G, Suter T, Arahmani A, Rouchet N, Clark E, Knott A, Lang I, Levy C, Yardley DA, Bines J, Gelber RD, Piccart M, Baselga J.
| Jun 05, 2017
16.

Aldehydes Pose a Threat to BRCA2 Mutation Carriers.

Cell.
Parmar K, D'Andrea AD.
| Jun 01, 2017
18.

Structural Basis for Regulation of ESCRT-III Complexes by Lgd.

Cell Rep.
McMillan BJ, Tibbe C, Drabek AA, Seegar TCM, Blacklow SC, Klein T.
| May 30, 2017
19.

Synergistic interactions with PI3K inhibition that induce apoptosis.

Elife.
Zwang Y, Jonas O, Chen C, Rinne ML, Doench JG, Piccioni F, Tan L, Huang HT, Wang J, Ham YJ, O'Connell J, Bhola P, Doshi M, Whitman M, Cima M, Letai A, Root DE, Langer RS, Gray N, Hahn WC.
| May 31, 2017
20.

Post-translational control of T cell development by the ESCRT protein CHMP5.

Nat. Immunol.
Adoro S, Park KH, Bettigole SE, Lis R, Shin HR, Seo H, Kim JH, Knobeloch KP, Shim JH, Glimcher LH.
| 05 29, 2017